The US company, which is aiming to bring back extinct species, says that it expects its first woolly mammoth calves will be born in the next three years.

Colossal Biosciences, the biotech company behind plans to try to bring back the woolly mammoth, Tasmanian tiger and the dodo, raised another $200 million for its research.

But Ben Lamm, CEO and founder of Colossal Biosciences, has said he's 'positive' the first woolly mammoth calves will be born in the next few years. 'Our recent successes in creating the ...

A prehistoric creature has just provided a stunning breakthrough, as a new research paper reveals that scientists mapped the three-dimensional architecture of a woolly mammoth's genome using ...

Woolly mammoth meat hasn't been on the menu for at least 5,000 years. A lab-grown meat company called Vow recently appeared to put the option back on the table by creating a "mammoth meatball ...

Learn More Colossal BioSciences has raised $200 million in a new round of funding to bring back extinct species like the woolly mammoth. Dallas- and Boston-based Colossal is making strides in the ...

It just looks warm. In a press release, Mammoth president Scott Taylor said company engineers “exceeded my wildest dreams” with the Wooly. “During testing, we were able to maintain 85F ...

(Bloomberg) -- A biotechnology startup working to bring back animals from extinction has raised $200 million at a valuation of $10.2 billion, more than six times its valuation just two years ago.